Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)
·Next Day Close·-1.73%·₹100.26
Key EventTrading window closes before results announcement
Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)
·Next Day Close·-0.03%·₹99.2
Key EventAnnual Report and AGM notice disclosed online for non-registered shareholders
ImpactShareholders can access the full annual report online without needing email registration.Sign up to read impact
Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)
·Next Day Close·+2.68%·₹99.72
Key EventBook closure for AGM
ImpactThis closure restricts trading in shares during the meeting period, potentially affecting liquidity but not altering company fundamentals.Sign up to read impact
Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)
·Next Day Close·+2.68%·₹99.72
Key Event36th AGM scheduled for September 30, 2026 at 3:00 PM via VC with financial statement adoption and director reappointment
ImpactShareholders must vote electronically on financials, director reappointment, and related party deals totaling up to ₹150 crores.Sign up to read impact
Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)
·Next Day Close·+2.68%·₹99.72
Key Event36th AGM scheduled for September 30, 2026 via video conferencing
ImpactNo dividend proposed despite ₹396.76 lakhs profit, with CSR obligations unmetSign up to read impact
Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)
·Next Day Close·+2.77%·₹97.66
Key EventBoard approved AGM date and annual report draft
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)
·Next Day Close·+1.95%·₹84.19
Key EventBoard approved unaudited Q1 FY26 standalone financial results and related disclosures.
ImpactThe company delivered modest profit growth in its first quarter, with no material deviations in fund utilization.Sign up to read impact
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)
·Next Day Close·-0.4%·₹91.5
Aarey Drugs & Pharmaceuticals Limited announced that its trading window closes on July 1, 2026, for insiders and designated persons until 48 hours after the unaudited Q1 results are declared, with the board meeting date to be announced later.
Sign up to read summaryAarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)
·Next Day Close·+2.28%·₹78.5
The board approved the audited standalone financial results for Q4 and FY2025-26 ending March 31, 2026, including an unmodified audit opinion, and confirmed the deviation statement for funds raised via convertible warrants. The meeting ran from 5:00 PM to 7:20 PM on May 30, 2026, with trading window opening 48 hours post-announcement per SEBI insider norms.
Sign up to read summaryAarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)
·Next Day Close·+4.98%·₹75.24
Aarey Drugs & Pharmaceuticals announced it received a SEBI-mandated certificate from MUFG Intime India Private Limited, its share transfer agent, confirming dematerialization of securities for the quarter ended March 31, 2026. The filing details the agent's role in verifying and updating shareholder records per Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018.
Sign up to read summary